Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
65 hedge funds and large institutions have $190M invested in Myovant Sciences Ltd. in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 10 closing their positions.
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
20% more funds holding
Funds holding: 54 → 65 (+11)
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
44% less capital invested
Capital invested by funds: $339M → $190M (-$149M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$6.71M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$3.16M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$3.04M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.41M |
| 5 |
Janus Henderson Group
London,
|
+$2.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$7.27M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.82M |
| 3 |
First Manhattan
New York
|
-$3.62M |
| 4 |
Millennium Management
New York
|
-$3.58M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.51M |
MYOV Hedge Fund Activity: Q3 2019 in Review
65 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q3 2019, worth a combined $190M — down 44% from $339M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new MYOV positions and 10 closed out — a net gain of 11 holders — while 17 added to existing stakes and 16 trimmed.
The largest buyer was Bellevue Group, adding an estimated $6.71M. The largest seller was Lord, Abbett & Co, cutting an estimated $7.27M.
- 65 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q3 2019, up from 54 in Q2 2019.
- Funds reported $190M of Myovant Sciences Ltd. stock for Q3 2019, down 44% quarter-over-quarter.
- 21 funds opened new Myovant Sciences Ltd. positions in Q3 2019 and 10 closed out, a net change of +11 holders.
- The largest Myovant Sciences Ltd. buyer in Q3 2019 was Bellevue Group, an estimated $6.71M added.
- The largest Myovant Sciences Ltd. seller in Q3 2019 was Lord, Abbett & Co, an estimated $7.27M sold.
Based on aggregated 13F filings for Q3 2019.